News

Video

AMCP’s Jennifer Mathieu Previews AMCP Nexus 2023

Jennifer Mathieu, MA, senior vice president of professional and government affairs of the Academy of Managed Care Pharmacy (AMCP), described what is in store for attendees during next week's AMCP Nexus meeting.

Jennifer Mathieu, MA, Jennifer Mathieu, MA, senior vice president of professional and government affairs of the Academy of Managed Care Pharmacy (AMCP), gave a sneak peek of what is in store for attendees during next week's AMCP Nexus meeting in Orlando, Florida. She provided an overview of the pre-conference session, the 30 education sessions, the general session speaker, and more.

Transcript

What can attendees look forward to at AMCP Nexus 2023?

To start from the top, I think one thing that's very exciting is that this is the first time that we're devoting so much time and space to this. On Monday, [October 16], we're going to be having a pre-conference session on the Inflation Reduction Act (IRA), and it's going to run for the entire afternoon on Monday.

[The meeting] will be kicked off by our board president Jim Hopsicker. We're going to hear from a multidisciplinary panel covering all of the stakeholder perspectives that are impacted by the IRA. We're going to hear from pharmaceutical manufacturers, we're going to hear from health plans, we're going to hear from PBMs [pharmacy benefit managers], we're going to hear from the academics, everyone who's been involved in understanding what the IRA, this huge piece of legislation, what it is, what it means for health care, how the drug negotiation program is going to impact pharmaceutical manufacturers, how the Part D reforms are going to impact payers and PBMs. We're going to have, like I said, that multidisciplinary panel start.

We're going to divide into 2 separate tracks, so pharmaceutical manufacturers are going to get to hear information specific to them, and our payers, our health plans, and our PBMs are going to get to hear information that's specific to them. Then, we'll bring it back together to close with that same multidisciplinary panel. I'll actually be doing the level setting overview of the IRA to kick the afternoon off after our board president does his welcome remarks.

We're really excited about the participation, the number of attendees we have, the speaker panels that we have, we're just really excited to be able to dive into this topic so thoroughly. We also feel that we're in a unique position at AMCP because our members work for all of the stakeholders who are impacted by this law and its implementation, so we're really excited to hear from all those diverse perspectives.

I think that's something that's going to be really exciting to kick off the week, kind of set the tone. Otherwise, we have over 30 education sessions throughout Tuesday, Wednesday, and Thursday of next week. We have 3 keynotes, everything from specialty pharmacy to the 340B program. And, of course, our general session speaker, Neil Pasricha; he's the Pied Piper of happiness, so we're really looking forward to hearing his message to our members.

All of our AMCP affiliates across the country are going to be meeting, all of our AMCP committees will be meeting. We have satellite symposia, we have an exhibit hall, we have some really, really great wellness and networking opportunities. So, just all around, I think folks can expect a big crowd. We've hit our numbers for registration and then some, so there's gonna be a lot of folks really interested in all of the managed care pharmacy topics that we'll be addressing next week.

Related Videos
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
dr carol regueiro
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
dr carol regueiro
Screenshot of Adam Colborn, JD during an interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo